Number of participants with adverse events after first vaccination 28 days after the first vaccination [clinicaltrials_resource:3fd33bd1c186a0ee498e88ef86940d7a]
To evaluate the adverse events of EV71 vaccine in healthy children and infants after first vaccination
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of participants with adverse events after first vaccination 28 days after the first vaccination [clinicaltrials_resource:3fd33bd1c186a0ee498e88ef86940d7a]
To evaluate the adverse events of EV71 vaccine in healthy children and infants after first vaccination
Bio2RDF identifier
3fd33bd1c186a0ee498e88ef86940d7a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3fd33bd1c186a0ee498e88ef86940d7a
measure [clinicaltrials_vocabulary:measure]
Number of participants with adverse events after first vaccination
time frame [clinicaltrials_vocabulary:time-frame]
28 days after the first vaccination
description
To evaluate the adverse events ...... nfants after first vaccination
identifier
clinicaltrials_resource:3fd33bd1c186a0ee498e88ef86940d7a
title
Number of participants with ad ...... ys after the first vaccination
@en
type
label
Number of participants with ad ...... 33bd1c186a0ee498e88ef86940d7a]
@en